Literature DB >> 782839

Which antirheumatic drug?

F D Hart.   

Abstract

Successful therapy in a chronic rheumatic disease means choosing the right drug for the right patient with the right condition at the right time. In the treatment of gout three different types of treatment are given: for the acute episode, suppression and long-term therapy. Misuse of long-term therapy for acute gout will often aggravate the condition. As regards rheumatoid arthritis, in the absence of a known aetiology, treatment is essentially empirical and palliative; the use of milder well-tolerated anti-inflammatory agents for the less severe cases, more effective and more toxic agents for the more severe cases, and slow acting long-term agents for those not responding to previous measures is discussed. Night pain and morning stiffness has its own therapy. The place of corticosteroids throughout the whole field of rheumatology is evaluated. In the treatment of systemic lupus erythematosus corticosteroids still hold first place, but the cytotoxic (immunosuppressive) agents also play a part, though an arguable one.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 782839     DOI: 10.2165/00003495-197611060-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  6 in total

1.  Inflammatory disease and its control in rheumatic disorders.

Authors:  F D Hart
Journal:  Br Med J       Date:  1975-10-25

2.  208.--INDOMETHACIN IN THE TREATMENT OF ACUTE GOUT.

Authors:  P L BOARDMAN; F HARTDUDLEY
Journal:  Practitioner       Date:  1965-04

Review 3.  Clinical studies on alclofenac in the treatment of rheumatic diseases: a drug in question.

Authors:  M Aylward
Journal:  Curr Med Res Opin       Date:  1975       Impact factor: 2.580

4.  Naproxen in ankylosing spondylitis.

Authors:  H F Hill; A G Hill
Journal:  Scand J Rheumatol Suppl       Date:  1973

5.  Azathioprine in rheumatoid arthritis: a long-term follow-up study.

Authors:  T Hunter; M B Urowitz; D A Gordon; H A Smythe; M A Ogryzlo
Journal:  Arthritis Rheum       Date:  1975 Jan-Feb

6.  Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Report of a prospective controlled trial in 24 patients.

Authors:  B H Hahn; O S Kantor; C K Osterland
Journal:  Ann Intern Med       Date:  1975-11       Impact factor: 25.391

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.